i 1.25 Hours

Course Overview

Parkinson’s disease is the second most common progressive neurodegenerative disease. It affects approximately 1 million people in the United States and 7 to 10 million people worldwide. Parkinson’s disease is characterized by the loss of dopaminergic neurons and has both motor and non-motor features. Cardinal features of Parkinson’s disease include resting tremor, rigidity, bradykinesia, and postural instability. As of the time of this writing, there is no approved disease-modifying treatment available. Management of Parkinson’s disease includes symptomatic treatment aimed at improving patients’ quality of life. While medications work well in managing patients’ symptoms initially, with disease progression and further loss of dopaminergic neurons, patients’ symptoms re-emerge and they begin to experience motor complications such as motor fluctuations and dyskinesias. These complications can be debilitating and can severely impact patients’ quality of life. Tailoring pharmacotherapy to account for these complications is often necessary in order for patients to maintain function. Similarly, screening for and treating non-motor symptoms is important in the management of Parkinson’s disease.

About the Course Author

Alexander Niyazov, PharmD, RPh, MPH, CPH, BCPS, is the Associate Director of Health Economics and Outcomes Research at Acorda Therapeutics. He has published and presented several works on Parkinson’s disease, chronic myeloid leukemia, and multiple sclerosis, and has taught Pharmacology adjunctively at a number of universities. Dr. Niyazov received his Doctor of Pharmacy from Long Island University. Alexander Niyazov, PharmD, RPh, MPH, CPH, BCPS has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.

Get started now and your first course is free!

Become a member today and enjoy instant savings on all courses

Accreditation Information

Certificates provided by accrediting body (1 Match)

  • Accreditation Council for Pharmacy Education


    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Type Activity: Knowledge
    Target Audience Designation: P
    ACPE Universal Activity Number: JA4008266-0000-21-156-H01-P

Course Details
  • Course Code:

  • Hours:

  • Type:

    Online Course
  • Release Date:

  • Expiration Date:

  • Learning Objectives:

    Discuss the management of motor symptoms in Parkinson’s disease; Discuss the management of non-motor symptoms for Parkinson’s disease; Identify the pathology of motor complications from Parkinson’s disease and discuss management options; Review the presentation and identification of Parkinson’s disease
  • Target Audience:

    The target audience for this course is: Pharmacists; in the following settings: Acute Care Facility.
  • Course Delivery Method and Format:

    Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
    Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
    If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
    All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
    Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
    All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
    To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
  • Accommodations:

    If you require special accommodations to complete this module, please contact Relias Customer Support here.
  • Disclosures:

    Expert Reviewers, Instructors, and Staff Writers disclosures will be listed above after the individuals' biographical paragraph. All other members involved within the planning of this educational activity have declared no conflict of interest exists when planning and developing this course.